Jul 28, 2023
5:4
For every 4 shares held, investors received 5. The price per share adjusted from $52.60 to $42.08.
The split itself did not change the total investment value.
GeneReach Biotechnology Corp. (TPEX:4171) operates in the Medical specialties industry.
GeneReach Biotechnology Corp. company overviewGeneReach Biotechnology Corp.'s most recent stock split was on July 28, 2023. It was a 5-for-4 forward split, so shareholders received 5 shares for every 4 they held.
GeneReach Biotechnology Corp. (TPEX:4171) has split its stock 3 times: a 349-for-339 split on October 7, 2021, a 11-for-10 split on September 13, 2022, and a 5-for-4 split on July 28, 2023.
GeneReach Biotechnology Corp. has split its stock 3 times. This history records 3 forward splits between October 7, 2021 and July 28, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In GeneReach Biotechnology Corp.'s 5-for-4 split on July 28, 2023, every 4 shares became 5 shares.
GeneReach Biotechnology Corp. has not announced a new split in our records. Its most recent split was on July 28, 2023, 3 years ago. Companies announce splits in advance, and any new TPEX:4171 split will appear on this page.
Already premium?